Abbott Laboratories stock trades at EUR 87.88 with volume 63.6 percent below average
Published on 10/08/2026 at 20:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Abbott Laboratories stock was at EUR 87.88 at Lang & Schwarz on October 8, 2026, plus 0.22 percent versus the prior close.
- Trading volume was 63.6 percent below the 9,557,664-share average, with 3,477,446 shares changing hands at the primary-market snapshot.
- Market capitalization was USD 170.2 billion, with a P/E ratio of 31.63 and a 0.03 percent dividend yield.
- Barclays began coverage with an Overweight rating and a USD 120.00 price target on October 7, 2026.
- Abbott Laboratories is scheduled to report third-quarter 2026 results on October 21, 2026.
Abbott Laboratories (ISIN US0028241000) was at EUR 87.88 at Lang & Schwarz on October 8, 2026 at 8:10 p.m. CEST, plus 0.22 percent versus the prior close. Trading volume was 3,477,446 shares, 63.6 percent below the 9,557,664-share average, making turnover the clearest market statistic in the after-hours snapshot.
Price sits inside yearly range
On the NYSE, Abbott Laboratories was last at USD 98.37 on October 8, 2026 at 2:17 p.m. ET, according to the listing identified by MarketBeat. The USD 81.97 to USD 135.13 52-week range places the stock 20.0 percent above its low and 27.2 percent below its high.
The primary-market quote gives a separate dollar reference from the euro after-hours price. Abbott Laboratories had a market capitalization of USD 170.2 billion, a P/E ratio of 31.63 and a 0.03 percent dividend yield on October 8, 2026.
Analyst target and earnings date
MarketBeat reported on October 7, 2026 that Barclays initiated coverage with an Overweight rating and a USD 120.00 price target. The target is USD 21.63 above the October 8 primary-market quote, a 22.0 percent difference calculated in the same currency.
MarketBeat lists October 21, 2026 for Abbott Laboratories' third-quarter 2026 results before the market opens, giving the next scheduled event a concrete date.
Comparison with peers
Abbott Laboratories (NYSE, USD): plus 0.22 percent, P/E 31.63, market capitalization USD 170.2 billion
Medtronic (NYSE, USD): plus 2.51 percent, P/E 21.55, market capitalization USD 112.2 billion
Boston Scientific Corporation (NYSE, USD): minus 0.34 percent, P/E 16.87, market capitalization USD 61.6 billion
After-hours quote remains near mid-range
Abbott Laboratories was at EUR 87.88 at Lang & Schwarz on October 8, 2026 at 8:10 p.m. CEST, plus 0.22 percent versus the EUR 87.69 prior close. The further course of trading is shown by the continuously updated real-time quote of Abbott Laboratories stock.
Abbott Laboratories stock facts
- Company: Abbott Laboratories
- ISIN: US0028241000
- Ticker: ABT
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 8, 2026, 8:10 p.m. CEST): EUR 87.88
- Change versus prior close: plus 0.22 percent
- Prior close Lang & Schwarz (October 7, 2026): EUR 87.69
- Market capitalization: USD 170.2 billion (as of October 8, 2026)
- 52-week range: USD 81.97-135.13 (as of October 8, 2026)
- Sector / Industry: Healthcare / Medical devices, diagnostics and pharmaceuticals
- Next earnings date: October 21, 2026
Market context: Market report S&P 500.
